Show simple item record

dc.contributor.authorRamírez, Laura
dc.contributor.authorde Moura, Luana Dias
dc.contributor.authorMateus, Natalia Lopes Fontoura
dc.contributor.authorde Moraes, Milene Hoehr
dc.contributor.authordo Nascimento, Leopoldo Fabrício Marçal
dc.contributor.authorde Jesus Melo, Nailson
dc.contributor.authorTaketa, Lucas Bezerra
dc.contributor.authorCatecati, Tatiana
dc.contributor.authorHuete, Samuel G.
dc.contributor.authorPenichet, Karla
dc.contributor.authorPiranda, Eliane Mattos
dc.contributor.authorde Oliveira, Alessandra Gutierrez
dc.contributor.authorSteindel, Mario
dc.contributor.authorBarral-Netto, Manoel
dc.contributor.authordo Socorro Pires e Cruz, Maria
dc.contributor.authorBarral, Aldina
dc.contributor.authorSoto Álvarez, Manuel 
dc.contributor.otherUAM. Departamento de Biología Moleculares
dc.date.accessioned2020-07-01T09:21:57Z
dc.date.available2020-07-01T09:21:57Z
dc.date.issued2020-02-01
dc.identifier.citationParasite Epidemiology and Control 8 (2020): e00126en_US
dc.identifier.issn2405-6731
dc.identifier.urihttp://hdl.handle.net/10486/691480
dc.description.abstractSerodiagnosis of Leishmania infantum infection in dogs relies on the detection of antibodies against leishmanial crude extracts or parasitic defined antigens. The expansion of canine leishmaniasis from geographical areas of Brazil in which the infection is endemic to regions in which the disease is emerging is occurring. This fact makes necessary the analysis of the serodiagnostic capabilities of different leishmanial preparations in distinct geographical locations. In this article sera from dogs infected with Leishmania and showing the clinical form of the disease, were collected in three distinct Brazilian States and were tested against soluble leishmanial antigens or seven parasite individual antigens produced as recombinant proteins. We show that the recognition of soluble leishmanial antigens by sera from these animals was influenced by the geographical location of the infected dogs. Efficacy of the diagnosis based on this crude parasite preparation was higher in newly endemic regions when compared with areas of high disease endemicity. We also show that the use of three of the recombinant proteins, namely parasite surface kinetoplastid membrane protein of 11 kDa (KMP-11), and two members of the P protein family (P2a and P0), can improve the degree of sensitivity without adversely affecting the specificity of the diagnostic assays for canine leishmaniasis, independently of the geographical area of residence. In addition, sera from dogs clinically healthy but infected were also assayed with some of the antigen preparations. We demonstrate that the use of these proteins can help to the serodiagnosis of Leishmania infected animals with subclinical infections. Finally, we propose a diagnostic protocol using a combination of KMP-11, P2a y P0, together with total leishmanial extractsen_US
dc.description.sponsorshipThis work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brazil) within the call“CNPq/MS/SCTIE/DECIT N° 32/2014 - Pesquisas sobre Leishmanioses”grant number reference 467389/2014-4. Institutional grants from the Fundación Ramón Areces and Banco de Santander to the CBMSO are also acknowledged. TC received scholarship from Fundação de Amparo a Pesquisa do Estado de Santa Catarina–FAPESCen_US
dc.format.extent12 pag.en_US
dc.format.mimetypeapplication/pdfen
dc.language.isoengen
dc.publisherElsevier BVen_US
dc.relation.ispartofParasite Epidemiology and Controlen_US
dc.rights© 2019 The Authorsen_US
dc.subject.otherAntibodiesen_US
dc.subject.otherCanine leishmaniasisen_US
dc.subject.otherLeishmaniaen_US
dc.subject.otherRecombinant proteinsen_US
dc.subject.otherSerodiagnosisen_US
dc.titleImproving the serodiagnosis of canine Leishmania infantum infection in geographical areas of Brazil with different disease prevalenceen_US
dc.typearticleen
dc.subject.ecienciaBiología y Biomedicina / Biologíaes
dc.relation.publisherversionhttps://doi.org/10.1016/j.parepi.2019.e00126
dc.identifier.doi10.1016/j.parepi.2019.e00126
dc.identifier.publicationfirstpagee00126-1
dc.identifier.publicationlastpagee00126-12
dc.identifier.publicationvolume8
dc.type.versioninfo:eu-repo/semantics/publishedVersionen
dc.rights.ccReconocimiento – NoComercial – SinObraDerivadaes_ES
dc.rights.accessRightsopenAccessen
dc.authorUAMSoto Álvarez, Manuel (260583)
dc.facultadUAMFacultad de Ciencias
dc.institutoUAMCentro de Biología Molecular Severo Ochoa (CBMSO)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record